GeoVax Stock Rockets Nearly 80% as Tiny Vaccine Developer Grabs Biodefense Spotlight
GeoVax Labs shares closed Monday at $2.21, up 79.7%, after the small vaccine developer announced a $3 million private placement and leaned into investor interest around biodefense preparedness. The stock was indicated lower in early premarket quotations Tuesday, after regular trading had not yet resumed.